United States Generic Drugs Market to Grow at a Steady CAGR of 9.43% During the Forecast Period
Increasing prevalence of cardiovascular diseases and diabetes is driving the growth of United States generic drugs market in the forecast period, 2022-2026. According to TechSci Research report, “ United States Generic Drugs Market By Type ( Small Molecule Generics v/s Biosimilars ), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious Diseases, Others), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others) , By Form (Tablet, Capsule, Injection, Others) , By Source (In House v/s Contract Manufacturing Organizations) , By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) , By Region, Competition, Forecast and Opportunity, 2026” the United States generic drugs market stood at USD70.78 billion in 2020 and is expected to grow at a steady CAGR of 9.43% during the forecast period on account of growing prevalence of diseases. The growing geriatric popul...